Open | - |
Close | - |
Volume / Avg. | 0 / 828.612K |
Day Range | - - - |
52 Wk Range | 24.285 - 79.650 |
Market Cap | $1.352B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 40 |
Short Interest | 15.77% |
Days to Cover | 6.61 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Prothena Corp (NASDAQ: PRTA) through any online brokerage.
Other companies in Prothena Corp’s space includes: Immunome (NASDAQ:IMNM), Gyre Therapeutics (NASDAQ:GYRE), Sage Therapeutics (NASDAQ:SAGE), Immatics (NASDAQ:IMTX) and Arcutis Biotherapeutics (NASDAQ:ARQT).
The latest price target for Prothena Corp (NASDAQ: PRTA) was reported by HC Wainwright & Co. on Wednesday, March 13, 2024. The analyst firm set a price target for 90.00 expecting PRTA to rise to within 12 months (a possible 257.71% upside). 27 analyst firms have reported ratings in the last year.
The stock price for Prothena Corp (NASDAQ: PRTA) is $25.16 last updated March 27, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Prothena Corp.
Prothena Corp’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for Prothena Corp.
Prothena Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.